Genitourinary

RENAL PELVIS, URETER, BLADDER, PROSTATE, URETHRA METASTATIC or UNRESECTED TRANSITIONAL CELL (T4b,N2-3, M1)

  • CALGB 90601 – A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma

KIDNEY

  • SWOG S0931- EVEREST: Everolimus for Renal Cancer Ensuing Surgical Therapy
  • ECOG E2810- A Randomized Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
  • Alliance A031203- A Randomized Phase II Study Comparing Cabozantinib (NSC#761968 and IND# 116059) With Commerically Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma (Temporary Closure)

PROSTATE

  • RTOG 0534 – A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
  • RTOG 0815 - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
  • RTOG 0924- A Phase III Trial of Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  • SWOG S1216- A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
  • Alliance A031201- A Phase III Trial of Enzalutamide (NSC #766085)  Versus Enzalutamide, Abiraterone, and Prednisone For Castration Resistant Metastatic Prostate Cancer

Metastatic Genitourinary

  • RTOG 0631- A Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis